Try our Advanced Search for more refined results
Life Sciences - June, 2011
176 articles
- Medicare Will Cover Avastin Despite FDA Ruling
- Elan, Abbott Drop Teva Patent Suit Over Tricor
- ViiV Goes After Lupin Over HIV Drug ANDA
- Ex-Ropes & Gray Atty Gets 30 Months In Prison
- Mercedes, T. Rowe Price Settle Web Patent Claims
- Merck, Sandoz Resolve Patent Suit Over Cancidas
- Impax Settles With Daiichi, Genzyme Over Generic Welchol
- Signalife, Investors Seek Approval For $4M Settlement
- Ex-Bio-Med Execs Can't Escape Convictions: 11th Circ.
- Somaxon Sues Mylan Again Over Generic Silenor
- FDA Panel Rules Avastin Unsafe For Breast Cancer Use
- EU, South Korea FTA To Address Nontariff Barriers
- Wilson Sonsini Snags Pharma Patent Pro From Foley
- Getting Specific About FCPA Compliance
- Doctors Blast Rosy Research For Medtronic Bone Device
- Judge Agrees With Watson's Take On Lidoderm Patent
- Roche Files 3 Patent Suits Over Generic Xeloda
- Pfizer Fights Aurobindo's Bid To Sell Generic Lipitor
- Medtronic Sues Edwards Over Heart Valve Patents
- Icahn Sues Forest Labs Over CEO Defense
- Mylan Takes $76M Antitrust Verdict To High Court
- UnitedHealth Seeks 2nd Remand Of GSK Paxil Action
- APP Takes Patent Contract Ruling To High Court
- AstraZeneca Sues Watson Over Generic Pulmicort
- Questions Remain On Class Certification Relitigation
- Zyprexa Payors' Off-Label Suit Denied By High Court
- Prandin Use Code Case Taken Up By High Court
- Atty Can't Represent AWP Classes, 1st Circ. Rules
- FDA Strengthens Warnings On Amgen, J&J Anemia Drugs
- W.Va. Supreme Court Revives Mylan Forum Challenge
- St. Jude Wins Injunction, Verdict Trimmed By $1.3B
- LeClairRyan Adds Roetzel White Collar Atty In DC
- 2nd Circ. Nixes $1.3B Asthma Drug Suit V. AstraZeneca
- Mylan Crohn's Drug Doesn't Infringe AstraZeneca IP: Judge
- Novelos Shakes Class Action Over Cancer Drug Statements
- UnitedHealth Wins Access To GSK Litigation Info
- Novo Hit With Overtime, Break Action From Sales Rep
- Teva Targets Apotex Over Generic Parkinson's Drug
- GSK To Pay States, DC $41M Over Drugmaking Lapses
- High Court Ruling May Hobble Suits Against Generics
- Smith & Nephew Wins $85M IP Verdict Against Arthrex
- Covidien Sales Rep OT Suit Should Be Certified: Judge
- Hospira Sued Over Infusion Patent, Sale Contract
- Feds Seek 30 Years For Doctor In $23M Medicare Fraud
- Mylan Resolves Shire Suit Over Generic Fosrenol
- Ex-'Biggest Loser' Hopeful Wraps Up Feud With Diet Cos.
- Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
- Breast Implants Aren't Forever, FDA Warns
- Understanding The Advice-Of-Counsel Defense
- Judge OKs Replacement Of Dead Class Rep In Paxil Suit
- Sens. Order Medtronic To Turn Over Infuse Records
- Skadden Reps Dentsply In $1.8B AstraZeneca Unit Buy
- Nationwide Bias Actions Are DOA Post-Dukes
- IP Cases To Watch At The District Court Level
- Claims Cut From Ex-Eisai Worker's Whistleblower Suit
- FDA Wants Relaxed Sterility Test Rules For Bio Products
- 25 Percent, 50 Percent ... What's In A Number?
- The FTC's War On 'Pay-For-Delay' Agreements
- Astellas Hits Sagent, Strides With Adenoscan IP Suit
- Sanofi Takes Sun To Court Over Generic Eloxatin
- Depomed Fights Generic Threat To Glumetza
- FDA Implements 9 Graphic Cigarette Warning Labels
- Richards Layton IT Guy Settles SEC Fraud Claims
- Wyeth Settles Patent Suit Over Generic Effexor
- Owner Of Ill. Weight Loss Clinics Charged With Fraud
- Fed. Circ. Tosses $5M Award Over Knee Surgery Patent
- High Court Declines To Weigh In On Patent Definiteness
- Supreme Court To Weigh Patentability Again In Mayo Case
- GSK Sues Roxane, Watson Over Generic Avodart
- J&J Wins 1st Trial Victory In Levaquin MDL
- High Court Won't Review $58M Award In Wyeth Drug Suit
- Fed. Circ. Stops Launch Of Watson's Generic Seasonique
- ITC Takes Up CSP's 337 Complaint Against Sued-Chemie
- How They Won It: Morgan Lewis Snags $577M Verdict For Asahi
- J&J Unit Recalls 40,000 Bottles Of Risperidone
- FDA Calls Back Boston Scientific Stents, Catheters
- HHS Wrongly Denied Hospital Reimbursements: DC Circ.
- J&J Faces Suit Over Benecol Cholesterol Claims
- AstraZeneca Drops Suit After Teva Nixes Generic Faslodex
- ThyssenKrupp Unit Settles With DOL In Sex Bias Row
- Judge Won't Block Watson's Generic Seasonique
- ConocoPhillips Unit Sues Trucking Co. Over PCB Cleanup
- How They Won It: Steptoe Gets Rare Acquittal For GSK Atty
- Somaxon Sues Zydus Over Generic Silenor
- GSK's Rotavirus Vaccine Tied To Bowel Disorder
- Q&A With Locke Lord's Graham Hill
- AGA Hits Occlutech With IP Suits In Germany, UK
- Inside Smith V. Bayer
- NY Court Refuses To Step Between Prosecutors, Amgen
- FDA Says Chantix Raises Risk Of Heart Attacks
- High Court Greenlights W.Va. Class Bid In Baycol Fight
- Apotex Can't Dodge Schering Suit Over Nasonex IP
- Ex-DHB Execs Face $150M Forfeiture For Stock Scheme
- 8th Circ. Weighs Women's Right To Pursue Wyeth Claims
- Novartis, Roxane Settle Famvir Dispute
- GSK Shakes Humana Suit Over Avandia Injury Costs
- FDA Widens Recall Of Boston Scientific Catheters
- Q&A With Fish & Richardson's John Adkisson
- Exec Says US Can't Prove Intent In Bone Cement Case
- Q&A With Dechert's Steven Weisburd
- 3rd Circ. Affirms Dismissal Of Amgen Tying Suit
- FDA Warns Matrixx Over Zicam Marketing
- 9th Circ. Refuses To Rehear Pfizer-Wyeth Merger Suit
- Novartis, Sun Settle IP Suit Over Generic Focalin
- FTC Seeks More Details On Teva's $6.8B Cephalon Buy
- Alcon Sues Watson To Block Pataday Generic
- Wis. Drug Cos. Face Temporary Shutdown After Raid
- Global 20: Reed Smith
- DOJ Subpoenas Gilead Over HIV Drugs
- Humira Patient Sues Abbott Over Fungal Infection
- Extra Damages Possible In $22M Stent Suit: Fed. Circ.
- Davis Polk Reps Aetna In $290M Genworth Buy
- Ex-Pfizer Reps Seek Classes For NY, Calif., Ill.
- Germany Suspends Takeda Diabetes Drug Actos
- Pharma Holdings Defendants Get 10 Days To Yield Docs
- Novo Settles Drug Marketing Claims For $26.7M
- FDA Says Prostate Drugs Can Cause Cancer
- Pfizer Sanctions Affirmed In Neurontin Antitrust MDL
- Whistleblower Protections Restored: Sylvester V. Parexel
- Warner Chilcott Sues Mylan Over Loestrin ANDA
- Jury Finds Against Baxter In Chinese Heparin Suit
- IP Lawyers Weigh In On Microsoft V. I4i Ruling
- Zocor Dangerous In High Doses, FDA Warns
- Cos. Brace For Calif. Green Chemistry Program
- FDA Takes First Step Toward Regulating Nanotechnology
- Roche, Genentech Sued Over Encryption Patent
- EU Court Adviser Sides With Merck In Patent Term Fight
- 2nd Circ. Affirms $11M Hit Against Taro Insider Traders
- UCB Agrees To Pay $34M Over Epilepsy Drug Labeling
- Lilly Sues Hetero To Block Generic Strattera
- Schering-Plough Denied Injunction In Sunscreen Suit
- Medical Food Makers Settle False Advertising Suit
- Lilly Wins TRO Battle In Byetta Marketing Case
- Global 20: Skadden
- Pfizer Unit Yanks Poultry Drug After FDA Arsenic Study
- 8th Circ. Again Upholds Catheter Maker's Antitrust Win
- Lawyer Dad Settles SEC Insider Trading Suit
- WellPoint Buys CareMore In Reported $800M Deal
- Forest Labs Sales Reps Win Class Cert. In OT Suit
- Firm Lied To Vioxx MDL Clients About Loans, Suit Says
- Global 20: Weil Gotshal & Manges
- Lundbeck Settles Antitrust Suit Over Infant Heart Drugs
- Fed. Circ. Affirms Invalidity Of J&J Stent Patents
- Be Careful What You Wish For, You Just Might GIT It
- Clarifying Obligation To Report Drug Patent Agreements
- Prior Art, Bird Feeder Not Comparable: Fed. Circ.
- 7th Circ. Questions Ex-Abbott Workers' ERISA Suit Bid
- McKesson, Hearst Inflated Drug Prices, Mich. AG Says
- AstraZeneca Settles DOL Sex Bias Pay Dispute
- FDA Warns Impax Over Drug Testing At Calif. Plant
- SEC Says Calif. Atty Stole Info On $2.8B Abbott Deal
- J&J Ordered To Pay $327M Over Risperdal Marketing
- Takeda Drops Suit Over Macleods' Actos ANDA
- Matrixx, Zicam Fail To Shut Down Cold Remedy MDL
- Lockheed Finds Way Out Of DataTern Patent Suit
- American Medical Settles Suits Over $2.9B Endo Buy
- Calif. County Seeks To Give US Drug Price-Fixing Docs
- Hearst Says Marie Claire Site Doesn't Violate Web Patent
- Pfizer Sues Watson Over Viagra ANDA
- GSK Denied Quick Win In Flonase Antitrust Cases
- SEC Widens Insider Trading Case Against FDA Chemist
- J&J Supplier Bugs Out Over Beetles In Bandages
- Pfizer Sues Impax Over Detrol ANDA
- Zicam Inventor Arrested Over Unapproved Bird Flu Drug
- Squire Sanders Nabs Health Care Prosecutor
- Ropes & Gray Snags Former Assistant US Atty
- Orthovita Shareholders Sue Over $316M Stryker Deal
- Goodell DeVries Opens Pa. Office With Ex-Dechert Attys
- Cooley Hires M&A Veteran From SNR Denton
- Implications Of Fed. Circ.'s Therasense Opinion
- Becton To Take Inequitable Conduct Fight To High Court
- Endo Sales Reps Win Conditional Cert. For OT Suit
- Allergan, Hi-Tech Settle IP Case Over Generic Combigan
- ReGen Sues FDA Over Menaflex Clearance Repeal
- Hydroxycut MDL Claims Fall Short, Judge Says
- FTC Signs Off On Grifols-Talecris Deal Divestitures